Not a fan? Unsubscribe here.
 

Daily Recap
Sponsored Content

Options Strategies Built for Market Reactions

Markets don’t move in straight lines—especially in 2026. Policy headlines and global uncertainty are creating sharp reactions across stocks and indexes.

For options traders, these reactions can translate into opportunities. We have released a new trading briefing, "Trade the Turbulence," designed specifically for this environment.

  • Volatility: Why emotional moves create repeatable setups.
  • Strategy: Two options plays built for pricing swings.
  • Discipline: A practical framework for when headlines hit.
Request the Free Options Report »

By clicking link you are subscribing to Premium Market News’s Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here. (Privacy Policy)

 
State of the Union: Trump expected to tout achievements ahead of midterms
State of the Union: Trump expected to tout achievements ahead of midterms
The president will make his case to Americans amid growing controversy over his domestic and foreign policies.

(learn more)
 
 
Sponsored Content

2026 Market Shift: 3 Small-Caps Showing Early Signals

Changes in small-cap activity often begin quietly. Rather than a loud announcement, they appear as gradual shifts in volume and participation.

As the year gets underway, our team has identified three lesser-followed companies displaying these exact early behaviors. They aren't widely covered yet, but the data suggests renewed interest is forming.

View the Free Research Update »

By clicking the link you will automatically be subscribed to the Stock News Trends Newsletter Privacy Policy

 
Despite Promise To Be Pro-Life ‘Ally,’ Trump Admin Won’t Regulate Abortion Drug Endangering Women
Despite Promise To Be Pro-Life ‘Ally,’ Trump Admin Won’t Regulate Abortion Drug Endangering Women
The FDA appears to be slow-walking its mifepristone review, frustrating Trump allies in both Congress and pro-life states.

(learn more)
 
 
 
Morning Minute: What Big News Will Come From the SOTU?
Morning Minute: What Big News Will Come From the SOTU?
 
 
 
 
Where patients live matters for access to gene therapy
Where patients live matters for access to gene therapy
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big hurdle for patients seekin...

(read more)

Keep Reading